Cargando…
Cardiac complications in community-acquired pneumonia and COVID-19
Community-acquired pneumonia (CAP) remains a global health problem with significant morbidity and mortality. Much recent published literature about the infection has indicated that a substantial number of patients with CAP, particularly those ill enough to be admitted to hospital, will suffer a card...
Autor principal: | Feldman, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
South African Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221539/ https://www.ncbi.nlm.nih.gov/pubmed/34235421 http://dx.doi.org/10.7196/AJTCCM.2020.v26i2.077 |
Ejemplares similares
-
Cardiovascular Complications in Community-Acquired Pneumonia
por: Desai, Antonio, et al.
Publicado: (2022) -
Biomarkers in Community-Acquired Pneumonia (Cardiac and Non-Cardiac)
por: Méndez, Raúl, et al.
Publicado: (2020) -
Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia
por: Anderson, Ronald, et al.
Publicado: (2018) -
Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumonia
por: Feldman, Charles, et al.
Publicado: (2016) -
The Role of Biomarkers in Influenza and COVID-19 Community-Acquired Pneumonia in Adults
por: Carbonell, Raquel, et al.
Publicado: (2023)